Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans.
Prabhu KS, Ahmad F, Kuttikrishnan S, Leo R, Ali TA, Izadi M, Mateo JM, Alam M, Ahmad A, Al-Shabeeb Akil AS, Bhat AA, Buddenkotte J, Pourkarimi E, Steinhoff M, Uddin S.
Prabhu KS, et al. Among authors: kuttikrishnan s.
Cell Death Discov. 2024 May 9;10(1):225. doi: 10.1038/s41420-024-01992-7.
Cell Death Discov. 2024.
PMID: 38724504
Free PMC article.